Published • loading... • Updated
Mahlman retiring as London Drugs president
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mahlman retiring as London Drugs president
RICHMOND, British Columbia — Clint Mahlman will step down as president and chief operating officer of London Drugs on Friday after more than 41 years with the company.He will be succeeded by Nick Curalli, who has been London's vice president of technology solutions since 2017. Curalli has been with London for more than 30 years. He started with the company as general manager of information technology before being named chief privacy officer in 2…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
